1 – 13 of 13
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
2024) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
- 2023
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
(
- Contribution to journal › Article
- 2022
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
(
- Contribution to journal › Article
- 2020
-
Mark
Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar
(
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article
- 2019
-
Mark
A study of neural activity and functional connectivity within the olfactory brain network in Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Olfactory fMRI : Implications of Stimulation Length and Repetition Time
(
- Contribution to journal › Article
- 2017
-
Mark
Olfactory Impairment in Parkinson's Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging
(
- Contribution to journal › Article
-
Mark
Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease
(
- Contribution to journal › Article
- 2016
-
Mark
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease : An open-label prospective observational study of effectiveness, tolerability and healthcare costs
(
- Contribution to journal › Article
- 2015
-
Mark
The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes
(
- Contribution to journal › Article
-
Mark
Consensus statement from the 2014 International Microdialysis Forum
(
- Contribution to journal › Article
- 2014
-
Mark
Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT
(
- Contribution to journal › Article